ND
New Day Fund
Venture Capital
BVI-registered biomedical investment fund controlled by Han Chao, focused on late-stage biopharma opportunities.
1+ investments
Late Stage
Growth
biotechnology
life sciences
pharmaceuticals
- Total Investment
- 1
- Last Investment
- Aug 2025
- Geographic Focus
- Asia, China
Investment Thesis
Biomedical sector fund focused on pre-IPO and late-stage biopharmaceutical investments.
New Day Fund is a Venture Capital firm. It has made 1 investment in biotechnology and life sciences.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.